These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 14613157

  • 21. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M, Gutteridge W, Zeman A, Dickins M, Woolley JL.
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [Abstract] [Full Text] [Related]

  • 22. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
    Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
    [Abstract] [Full Text] [Related]

  • 23. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
    Yeo AE, Seymour KK, Rieckmann KH, Christopherson RI.
    Biochem Pharmacol; 1997 Apr 04; 53(7):943-50. PubMed ID: 9174107
    [Abstract] [Full Text] [Related]

  • 24. Recent patent reviews on small molecule-based antimalarial drugs.
    Elsohly MA, Gul W.
    Recent Pat Antiinfect Drug Discov; 2007 Nov 04; 2(3):222-32. PubMed ID: 18221180
    [Abstract] [Full Text] [Related]

  • 25. Antimalarial drug resistance and combination chemotherapy.
    White N.
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr 29; 354(1384):739-49. PubMed ID: 10365399
    [Abstract] [Full Text] [Related]

  • 26. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
    Canfield CJ, Pudney M, Gutteridge WE.
    Exp Parasitol; 1995 May 29; 80(3):373-81. PubMed ID: 7729473
    [Abstract] [Full Text] [Related]

  • 27. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J.
    Microbes Infect; 2006 Sep 29; 8(11):2599-604. PubMed ID: 16962361
    [Abstract] [Full Text] [Related]

  • 28. Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone/proguanil.
    Koch S, Göbels K, Richter J, Oette M, Häussinger D.
    Parasitol Res; 2007 Mar 29; 100(4):747-8. PubMed ID: 17004096
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antimalarial compounds: from bench to bedside.
    Olliaro PL, Taylor WR.
    J Exp Biol; 2003 Nov 29; 206(Pt 21):3753-9. PubMed ID: 14506210
    [Abstract] [Full Text] [Related]

  • 33. Some pharmacological aspects of antimalarial drugs.
    Botha D.
    S Afr Med J; 1974 Jun 15; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
    Lütgendorf C, Rojanawatsirivet C, Wernsdorfer G, Sirichaisinthop J, Kollaritsch H, Wernsdorfer WH.
    Wien Klin Wochenschr; 2006 Jun 15; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The genomic architecture of antimalarial drug resistance.
    Cowell AN, Winzeler EA.
    Brief Funct Genomics; 2019 Sep 24; 18(5):314-328. PubMed ID: 31119263
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
    Tahar R, Almelli T, Debue C, Foumane Ngane V, Djaman Allico J, Whegang Youdom S, Basco LK.
    J Infect Dis; 2014 Dec 15; 210(12):1962-71. PubMed ID: 24943722
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.